Protective effect of Chrysin as Antioxidant, Anti-inflammatory and Anti apoptotic agent in Transient global cerebral Ischemia - Reperfusion injury among diabetic rats

Orsu Prabhakar

doi:10.52711/0974-360X.2021.00364

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Protective effect of Chrysin as Antioxidant, Anti-inflammatory and Anti apoptotic agent in Transient global cerebral Ischemia - Reperfusion injury among diabetic rats

Author(s): Orsu Prabhakar

Email(s): orsuprabhakar@gmail.com

DOI: 10.52711/0974-360X.2021.00364

Address: Orsu Prabhakar
Gitam Institute of Pharmacy, Gitam Deemed to be University, Visakhapatnam, India - 530045.
*Corresponding Author

Published In: Volume - 14, Issue - 4, Year - 2021

View HTML

View PDF

ABSTRACT:
Aim: Oxidative stress, inflammation and apoptosis have been implicated as pathological conditions in ischemic stroke, further these conditions worsen in the presence of diabetes. This study was designed to investigate whether the chrysin has protective role against ischemia reperfusion injury through anti-oxidant, anti-inflammatory and anti-apoptosis mechanisms in diabetic rats. Methods: Streptozocine (50mg/kg) intraperitonially given at once to induce the diabetes. Common carotid artery occlusion (30 min) and reperfusion (4 hr) was employed to induce cerebral infarction in diabetic rats. The animals were divided in to groups as: normal, sham, ischemia-reperfusion and chrysin treated (10, 20, 30 and 40mg/kg). These were used for estimation of percentage of cerebral infarction. 30mg/kg dose was used for further estimation of inflammatory markers like TNF-a, IL-6, IL-10 and oxidative stress markers (xanthine oxidase, glutathione, NADPH, malondialdehyde, superoxide dismutase and catalase), apotosis markers (Bcl2, BAX and Hsp90) were estimated and also glutamate and aspartate levels were measured in brain tissues. Results: Dose dependent reduction in percentage of cerebral infarction was observed in chrysin treated groups. With chyrsin 30mg/kg the apoptosis, inflammatory and oxidative stress markers like BAX, Hsp90, TNF-a, IL-6, myeloperoxidase, malondialdehyde, NADPH and xanthine oxidase levels were reduced and there was a significant increase in anti-apoptosis, anti-inflammatory and anti-oxidant markers like Bcl2, IL-10 levels and glutathione, catalase, superoxide dismutase which was also accompanied with elevated glutamate and aspartate levels. Conclusion: Collectively, these results show that chrysin possess a cerebroprotective effect against ischemic reperfusion injury in the diabetic rats.

Keywords:

Cite this article:
Orsu Prabhakar. Protective effect of Chrysin as Antioxidant, Anti-inflammatory and Anti apoptotic agent in Transient global cerebral Ischemia - Reperfusion injury among diabetic rats. Research Journal of Pharmacy and Technology. 2021; 14(4):2049-4. doi: 10.52711/0974-360X.2021.00364

Cite(Electronic):
Orsu Prabhakar. Protective effect of Chrysin as Antioxidant, Anti-inflammatory and Anti apoptotic agent in Transient global cerebral Ischemia - Reperfusion injury among diabetic rats. Research Journal of Pharmacy and Technology. 2021; 14(4):2049-4. doi: 10.52711/0974-360X.2021.00364 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-40

REFERENCES:

1. George MG, Fischer L, Koroshetz W, Bushnell C, Frankel M, Foltz J, Thorpe PG. CDC Grand Rounds: Public Health Strategies to Prevent and Treat Strokes. MMWR Morb Mortal Wkly Rep 2017; 66(18): 479-481. DOI: 10.15585/mmwr.mm6618a5.

2. Shukla V, Shakya A. K, Perez-Pinzon M. A and Dave K. R. Cerebral ischemic damage in diabetes: an inflammatory perspective. Journal of neuroinflammation 2017; 14(1): 21. DOI:10.1186/s12974-016-0774-5.

3. Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. The American journal of the medical sciences 2016; 351(4): 380–386. DOI: 10.1016/j.amjms.2016.01.011.

4. Maiocchi S, Alwis I, Wu MCL, Yuan Y, Jackson SP. Thromboinflammatory Functions of Platelets in Ischemia-Reperfusion Injury and Its Dysregulation in Diabetes. Semin Thromb Hemost 2018; 44(2): 102-13.

5. Canbaz S, Duran E. Ischaemia-reperfusion studies and diabetes mellitus. Br J Anaesth 2003; 91: 158-9.

6. Ramírez-Espinosa JJ, Saldaña-Ríos J, García-Jiménez S, Villalobos-Molina R, Ávila-Villarreal G, Rodríguez-Ocampo AN, Bernal-Fernández G, Estrada-Soto S. Chrysin Induces Antidiabetic, Antidyslipidemic and Anti-Inflammatory Effects in Athymic Nude Diabetic Mice. Molecules 2017; 28: 23(1): pii: E67. DOI: 10.3390/molecules23010067.

7. Veerappan R, Malarvili T. Chrysin Pretreatment Improves Angiotensin System, cGMP Concentration in L-NAME Induced Hypertensive Rats. Indian J Clin Biochem 2019; 4(3): 288-295. DOI: 10.1007/s12291-018-0761-y.

8. Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, Huang CY, Chen YW, Chen CN. Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. J Agric Food Chem 2012;60(47):11748-58. DOI: 10.1021/jf303261r.

9. Sharma P, Kumari A, Gulati A, Krishnamurthy S, Hemalatha S. Chrysin isolated from Pyrus pashia fruit ameliorates convulsions in experimental animals. Nutr Neurosci 2019;22(8): 569-577. doi: 10.1080/1028415X.2017.1418786.

10. Orsu P, Murthy BV, Akula A. Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm 2013;120(8):1217-23. DOI: 10.1007/s00702-013-0982-4.

11. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nat Protoc 1(6) (2006) 3159-65.

12. Okhawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction, Anal Biochem 1979;95: 351–8. DOI: 10.1016/0003-2697(79)90738-3.

13. El Khashab IH, Abdelsalam RM, Elbrairy AI, Attia AS. Chrysin attenuates global cerebral Ischemic Reperfusion injury via suppression of oxidative stress, inflammation and apoptosis. Biomed Pharmacother 2019; 112:108619. DOI: 10.1016/j.biopha.2019.108619.

14. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Bio Chem Biophys 1984; 21:130-2.

15. Aebi H. Catalase: Methods in enzymatic analysis Vol. II 1974; (ed. H.U. Bergmer) 673-84.

16. Liu N, Chen R, Du H, Wang J, Zhang Y, Wen J. Expression of IL-10 and TNF-alpha in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell Mol. Immunol 2009; 6: 207-13.

17. Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996; 206: 149–2.

18. Wang X1, Luo Y, Sun H, Feng J, Ma S, Liu J, Huang B. Dynamic expression changes of Bcl-2, Caspase-3 and Hsp70 in middle cerebral artery occlusion rats. Brain Inj 2015; 29(1): 93-7. DOI: 10.3109/02699052.2014.945958.

19. Wenting Z, Aiguo M. MicroRNA-124 expression in the brains of rats during early cerebral ischemia and reperfusion injury is associated with cell apoptosis involving STAT3. Exp Ther Med 2019;17(4): 2870–2876. DOI: 10.3892/etm.2019.7220.

20. Sundaram TK, Cazzulo JJ, Kornberg HL. Synthesis of pyruvate carboxylase from its apoenzyme and (+)-biotin in Bacillus stearothermophilus. Mechanism and control of the reaction. Biochem J 1971; 122(5): 663-9.

21. Shah SA, Amin FU, Khan M, Abid MN, Rehman SU, Kim TH, Kim MW, Kim MO. Anthocyanins abrogate glutamate-induced AMPK activation, oxidative stress, Neuroinflammation, and Neurodegeneration in postnatal rat brain. J Neuroinflammation 2016; 13 (1): 286.

22. Khan M, Siphon B, Jatana M, Giri S et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 2004; 76: 519-7.

23. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009;7: 97.

24. Nabavi SF, Braidy N, Habtemariam S, Orhan IE, Daglia M, Manayi A, Gortzi O, Nabavi SM. Neuroprotective effects of chrysin: From chemistry to medicine. Neurochem Int 2015; 90: 224-31. DOI: 10.1016/j.neuint.2015.09.006.

25. Goes ATR, Jesse CR, Antunes MS, Lobo Ladd FV, Lobo Ladd AAB, Luchese C, Paroul N, Boeira SP. Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins. Chem Biol Interact 2018; 279:111-120. DOI: 10.1016/j.cbi.2017.10.019.

26. Guo B, Zheng C, Cai W, Cheng J, Wang H1, Li H, Sun Y, Cui W, Wang Y, Han Y, Lee SM, Zhang Z. Multifunction of Chrysin in Parkinson's Model: Anti-Neuronal Apoptosis, Neuroprotection via Activation of MEF2D, and Inhibition of Monoamine Oxidase-B. J Agric Food Chem 2016; 64(26):5324-33. DOI: 10.1021/acs.jafc.6b01707.

27. Prabhakar O. Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 2013; 386(8): 705-10. doi: 10.1007/s00210-013-0871-2.

28. Mani R, Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry 2018; 145:187-196. doi: 10.1016/j.phytochem.2017.09.016.

29. Zeinali M, Rezaee SA, Hosseinzadeh H. An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substance. Biomed Pharmacother 2017; 92: 998-1009.

30. Anne Lejay, Fei Fang, Rohan John, Julie A.D. Van, Meredith Barr, Fabien Thaveau et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. Journal of Molecular and Cellular Cardiology 2016; 91:11-22.

31. Neven Zarkovic. Antioxidants and Second Messengers of Free Radicals. Antioxidants 2018; 7(1): 158.

32. O.M. Ighodaro, O.A. Akinloye. First line defense antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defense grid. Alexandria Journal of Medicine 2018; 54(4): 287-293.

33. Saima Naz, Muhammad Imran, Abdur Rauf, Ilkay Erdogan Orhan, Mohammad Ali Shariati, Iahtisham-Ul-Haq et al. Chrysin: Pharmacological and therapeutic properties. Life Sciences 2019; 235: 116797.

34. Gouwy M, Struyf S, Proost P, Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005; 16: 561-80.

35. Yasuda Y, Shimoda T, Uno K et al. Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global Ischemia in rats. J Neuroinflammation 2011; 8 :70.

36. Tangming Peng, Yizhou Jiang, Mohd Farhan, Philip Lazarovici, Ligang Chen, and Wenhua Zheng. Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy. Front Pharmacol 2019; 10: 204. doi: 10.3389/fphar.2019.00204.

37. Eman M. Mantaway et al. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. Sci Rep 2017; 2: 4795.

38. Mao Nakayama. Neuroprotective effects of flavonoids on hypoxia, glutamate-and oxidative stress–induced retinal ganglion cell death. Mol Vis 2011; 17: 1784-1793